Neudle.com: multiple sclerosis primary progressive

Differential
(Click to cross reference)

abducens nerve paralysis

abscess, intracerebral

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acute disseminated encephalomyelitis

acute necrotizing encephalitis

adenylate kinase 5 autoantibodies

adverse drug reaction

affect, flat

Alexanders disease

Alexanders disease, adult onset

amphiphysin antibodies

amyloid angiopathy, cerebral

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, misdiagnosis

amyotrophic lateral sclerosis, work up

aneurysm

aneurysm, cavernous sinus

aneurysm, internal carotid artery

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

anti Hu antibody

antibiotics

antihistamines

arterial dissection, aorta

arteriovenous malformation

arteriovenous malformation, cerebral

autoimmune cerebellar ataxia

Barkhof MR criteria for MS

behavioral disorder

Behcet's syndrome

bone marrow biopsy

bone marrow suppression

brain biopsy

brainstem, lesion of

brucellosis, nervous system involvement with

Brudzinski's sign

carbon monoxide poisoning

CAT scan, emission, abnormal

CAT scan, serial

cavernous sinus, syndrome

central nervous system, infection of

central pontine myelinolysis

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellar pontine angle tumor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral infarction

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular disease

cervical rib

cervical spine

cervical spondylosis

cervical spondylosis, differential diagnosis of

cervical spondylosis, misdiagnosis

chemotherapy, CNS treatment and complications with

Clinical Pathologic Conference(C.P.C.)

clinicoradiologic dissociation

collagen vascular disease

collapsin response mediator protein 5 IgG

complications

concentric sclerosis

confusion

contactin associated protein like 2 antibodies

controversies in neurology

cop 1

corpus callosum

corpus callosum, infarction of

corpus callosum, lesion of

corpus callosum, neoplasm of

cortical blindness

cost effectiveness

cranial neuropathy

cranial neuropathy, multiple

crying, pathologic

cryptococcal meningitis

cyclophosphamide

cyclosporine

cytomegalovirus infection

degenerative diseases of CNS

delirium

dementia

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dermatomyositis

diabetes mellitus

diarrhea

differential diagnosis

diffuse axonal injury

disability rating scale, neurological

disability, neurological

disease modifying agents

drug abuse

drug induced neurologic disorders

dysarthria

dysphagia

efficacy

electroencephalogram, abnormalities of

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

epidemiology of neurology

facial weakness, bilateral

gammaglobulin therapy, intravenous

genu of corpus callosum

glioblastoma multiforme(astrocytoma Gr.III)

glioma

gliomatosis cerebri

glutamic acid decarboxylase, antibody

gray matter

Guillain Barre syndrome

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

herpes simplex virus

herpes virus infection

herpes zoster

heterochromia iridis

highly active antiretroviral therapy

hippocampal atrophy

hippocampus

hippocampus, hyperintense

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

Horner's syndrome

Horner's syndrome, etiologies of

human immunodeficiency virus type 1

hydrocephalus

hyperreflexia

hypertension

hypertensive encephalopathy

iatrogenic neurologic disorders

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

intellectual deterioration

interferon

interferon beta 1-a

interferon beta 1-b

intracerebral hemorrhage

Jakob-Creutzfeldt disease

JC virus

Kernig's sign

Klumpke palsy

laminectomy, cervical

laughing, pathologic

leucine rich glioma inactivated 1 antibodies

leukodystrophy

leukoencephalopathy

leukoencephalopathy, differential diagnosis

levamisole

level of consciousness, decreased

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

malformation, vascular, cerebral

malignancy screen

malignancy, occult

Marchiafava-Bignami disease

memory, defect of recent

memory, impairment of

mental status, abnormal

mesial temporal lobe

methotrexate

middle cerebellar peduncle

middle cerebellar peduncle, lesion

migraine

miosis

misdiagnosis

mitochondrial disease

mitoxantrone

monoclonal antibodies

mononeuropathy

mononeuropathy multiplex

motor neuron disease

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, contrast enhanced, delayed

MRI, contrast enhanced, high dose

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

multiple sclerosis, benign form of

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

myasthenia gravis, paraneoplastic

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic examination

neurologic practice

neurologic signs

neuromuscular junction

neuronal cell surface antigen

neuronopathy, sensory

neuropathology

neuropathy

neuropathy, paraneoplastic

neuropathy, sensory

NMDA antagonists

ocrelizumab

onconeural antibodies

opportunistic infection

opportunistic infection, CNS

opsoclonus-myoclonus syndrome

otitis, neurologic complications with

palatal myoclonus

pancoast tumor

paraneoplastic cerebellar degeneration

paraparesis

paraparesis, spastic

paraproteinemia

paratrigeminal syndrome

peripheral nerve, lesion of

PLEDs, bilateral independent

PLEDs, etiology of

pleocytosis of cerebrospinal fluid

poliomyelitis

polyneuropathy

posterior inferior cerebellar artery syndrome

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

prosopagnosia

pseudobulbar palsy

psychological testing

psychomotor retardation

pulmonary nodules

pupil

pupil, abnormality in neurologic disorders

pyramidal tract dysfunction

quadriparesis

quadriplegia

quality of life

radiation therapy, CNS treatment and complications with

radiculitis

rapidly progressing neurologic illness

ReBUILD study

Red flags

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

shunt procedure, ventricular

shunt procedure, ventricular-complications of

sinusitis

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

spasticity

speech disorder

speech, loss of

spinal cord, compression of

spondylosis

steroid

steroid therapy, CNS treatment and complications with

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

symmetric brain lesions

syphilis, diagnosis and treatment

syphilis, neurologic complications with

syringomyelia

systemic lupus erythematosus

tau protein

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

Thies's sign

thrombocytopenia

thyroiditis

tongue, impaired movements of

tonsillectomy

toxic encephalopathy

toxoplasmosis, acquired

toxoplasmosis, CNS

transient neurologic deficit

treatment of neurologic disorder

trigeminal neuropathy

trigeminal neuropathy, sensory

tuberculosis

tumor necrosis factor

tumor necrosis factor inhibitor

vaccination, neurologic complications with

vaccine

vasculitides

vasculopathy

vertebral-basilar insufficiency

viral infection

viral infection, CNS

viral infection, reactivation

visual evoked response

visual loss

Waldenstrom's macroglobulinemia

walking, difficulty with

white matter, dirty-appearing

workup

xerophthalmia

xerostomia

Showing articles 1450 to 1500 of 9318 << Previous Next >>

HIV-associated Neurologic Disease Incidence Changes: Multicenter AIDS Cohort Study, 1990-1998
Neurol 56:257-260, Sacktor,N.,et al, 2001

La Crosse Encephalitis in Children
NEJM 344:801-807, McJunkin,J.E.,et al, 2001

Hepatitis B Vaccination and the Risk of Multiple Sclerosis
NEJM 344:327-332,372,381, Ascherio,A.,et al, 2001

Vaccinations and the Risk of Relapse in Multiple Sclerosis
NEJM 344:319-326,372, Confavreux,C.,et al, 2001

Sudden Sensorineural Hearing Loss Associated with Herpes Simplex Virus Type 1 Infection
Neurol 56:571-572, Rabinstein,A.,et al, 2001

Assessing the Risk of Early Multiple Sclerosis in Patients with Clinically Isolated Syndromes: the Role of a Follow Up MRI
JNNP 70:390-393, Brex,P.A.,et al, 2001

European/Canadian Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Effects of Glatiramer Acetate on Magnetic Resonance Imaging-Measured Disease Activity and Burden in Patients wi
Ann Neurol 49:290-297, Comi,G.,et al, 2001

Hospitalization in Amyotrophic Lateral Sclerosis, Causes, Costs, and Outcomes
Neurol 56:753-757, Lechtzin,N.,et al, 2001

Seizures in Multiple Sclerosis
Epilepsia 42:72-79, Sokic,D.V.,et al, 2001

Clinicopath Conf,Mononeuritis Multiplex Due to Systemic Amyloidosis
NEJM 344:917-923, Case 9-2001, 2001

The Influence of Cognitive Impairment on Driving Performance in Multiple Sclerosis
Neurol 56:1089-1094, Schultheis,M.R.,et al, 2001

CSF Oligoclonal Bands in MS Include Antibodies Against Chlamydophila Antigens
Neurol 56:1168-1176,1126,1128,1130, Yao,S.,et al, 2001

Presence of Chlamydia pneumoniae DNA in the Cerebral Spinal Fluid is a Common Phenomenon in a Variety of Neurological Diseases and Not Restricted to Multiple Sclerosis
Ann Neurol 49:585-589,556, Gieffers,J.,et al, 2001

Disability and Quality of Life in Charcot-Marie-Tooth Disease Type 1
JNNP 70:548-550, Pfeiffer,G.,et al, 2001

Evolution of Cerebral Infarct Volume Assessed by Diffusion-Weighted Magnetic Resonance Imaging
Arch Neurol 58:613-617, Lansberg,M.,G.,et al, 2001

Diffusion-Weighted Imaging and National Institutes of Health Stroke Scale in the Acute Phase of Posterior-Circulation Stroke
Arch Neurol 58:621-628, Linfante,I.,et al, 2001

Comparisons of Patient Self-report, Neurologic Examination, and Functional Impairment in MS
Neurol 56:934-937, Hoogervorst,E.L.J.,et al, 2001

Recurrent Reversible Paraplegia
Lancet 357:1092, Haran,M. & Ni,S., 2001

Clinical and Neuroradiologic Features of Acute Disseminated Encephalomyelitis in Children
Neurol 56:1308-1312,1257, Hynson,J.L.,et al, 2001

Measurement of Antibodies to Interferon Beta in Patients With Multiple Sclerosis
Arch Neurol 58:1299-1300,1301, Pachner,A.R., 2001

The Significance of Neutralizing Antibodies in Patients With Multiple Sclerosis Treated With Interferon Beta
Arch Neurol 58:1297-1298,1301, Rice,G., 2001

Inclusiong Body Myositis Mimicking Motor Neuron Disease
Arch Neurol 58:1253-1256, Dabby,R.,et al, 2001

14-3-3 Protein in the CSF as Prognostic Marker in Early Multiple Sclerosis
Neurol 57:722-724, Martinez-Yelamos,A.,et al, 2001

MRI Characteristics of the MLF in MS Patients with Chronic Internuclear Ophthalmoparesis
Neurol 57:762-768, Frohman,E.M.,et al, 2001

Nonpoliovirus Poliomyelitis Simulating Guillain-Barre Syndrome
Arch Neurol 58:1460-1464, Gorson,K.C.&Ropper,A.H., 2001

Tourette's Syndrome
NEJM 345:1184-1192, Jankovic,J., 2001

Reversible ALS-Like Disorder in HIV Infection
Neurol 57:995-1001,945, Moulignier,A.,et al, 2001

Handicap After Acute Whiplash Injury
Neurol 56:1637-1643, Kasch,H.,et al, 2001

Autologous Hematopoietic Stem Cell Transplantation Suppresses Gd-enhanced MRI activity in MS
Neurol 57:62-68, Mancardi,G.L.,et al, 2001

A Three-item Scale for the Early Prediction of Stroke Recovery
Lancet 357:2095-2099, Baird,A.E.,et al, 2001

PRISMS-4: Long-Term Efficacy of Interferon-B-1a in Relapsing MS
Neurol 56:1628-1636,1620, The PRISMS Study Group, 2001

Acute Motor Radiculopathy as a First Symptom of MS: Anatomic-radiologic Correlation
Neurol 56:1603-1604, Lavallee,P.,et al, 2001

A Longitudinal MRI Study of Histopathologically Defined Hypointense Multiple Sclerosis Lesions
Ann Neurol 49:793-796, Bitsch,A.,et al, 2001

Amyotrophic Lateral Sclerosis
NEJM 344:1688-1700, Rowland,L.P. & Shneider,N.A., 2001

Effect of Early Interferon Treatment on Conversion to Definite Multiple Sclerosis: A Randomised Study
Lancet 357:1576-1582,1547, Comi,G.,et al, 2001

Clinical Presentation of Left Atrial Cardiac Myxoma
Medicine 80:159-172, Pinede,L.,et al, 2001

Acute Disseminated Encephalomyelitis
Neurol 56:1313-1318,1257, Schwarz,S.,et al, 2001

Fulminant Liver Failure During Interferon Beta Treatment of Multiple Sclerosis
Neurol 56:1416, Yoshida,E.M.,et al, 2001

Brainstem Gliomas in Adults: Prognostic Factors and Classification
Brain 124:2528-2539, Guillamo,J.-S.,et al, 2001

Onset of Multiple Sclerosis Associated With Anti-TNF Therapy
Neurol 57:1885-1888, Sicotte,N.L. &Voskuhl,R.R., 2001

Fluid-Attenuated Inversion Recovery Magnetic Resonance Imaging Detects Cortical and Juxtacortical Multiple Sclerosis Lesions
Arch Neurol 58:742-748, Bakshi,R.,et al, 2001

Differential Diagnosis of Posterior Fossa Multiple Sclerosis Lesions--Neuroradiological Aspects
Neurol Sci 22 Suppl 2:S79-83, Falini,A.,et al, 2001

Acute Bilateral Sensorineural Hearing Loss as the Presenting Symptom of Metastatic Lung Cancer
Otolaryngol Head Neck Surg 124:592-594, Snyder, M.C. & Heywood, B., 2001

Pituitary Lymphoma Presenting as Fever of Unknown Origin
J Clin Endocrinol Metab 86:1470-1476, Landman, R.E.,et al, 2001

Ataxia Associated with Hashimotos Disease: Progressive Non-Familial Adult Onset Cerebellar Degeneration with Autoimmune Thyroiditis
JNNP 71:81-87, Selim, M. and Drachman, D.A., 2001

Reduced Signal Intensity of T2 Weighted MR Imaging of Thalamus and Putamen in Multiple Sclerosis in Japan
Rinsho Shinkeigaku 40:677-682, Nishii,T.,et al, 2000

Disorders of Upper & Lower Motor Neurons
Neurol in Clin Practice, 3rd Ed., Butterworth, Boston: Ch. 78 p. 2007, Mitasumoto,H., 2000

Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR 21:702-706, Tintore,M.,et al, 2000

Stroke Prevention
Neurol Clin 18:321-341, Wein,T.H. &Bornstein,N.M., 2000

Significance of Surgical Resection for the Treatment of Multiple Brain Metastases
Anticancer Res 20:573-577, Iwadate,Y.,et al, 2000

Showing articles 1450 to 1500 of 9318 << Previous Next >>